[On the treatment of obstetrical and gynecological bleedings with a new anti-fibrinolytic agent].
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D008722:Methods; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D014592:Uterine Hemorrhage / Q000188:drug therapy* / Q000209:etiology
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids
Uber die Behandlung geburtshilficher und gynäkologischer Blutungen mit einem neuen Antifibrinolytikum.